ALung completes pilot research of Hemolung RAS in COPD patients ALung Technology.

We are pleased to have finished our pilot study of the Hemolung RAS and to be progressing towards obtainment of the CE tag, said Peter DeComo, ALung’s Chairman and CEO. There is definitely tremendous medical enthusiasm for the Hemolung RAS, and we’re looking towards introducing the merchandise to crucial reference centers throughout European countries soon. .. ALung completes pilot research of Hemolung RAS in COPD patients ALung Technology, Inc., a leading programmer of innovative lung support devices, presented an evaluation of its recent medical trial of the Hemolung Respiratory Help System in patients with acute exacerbation of chronic obstructive pulmonary disease . The data were presented through the program Chronic and Acute Hypercapnic Failing – Management with low flow CO2 devices on Friday, June 15th at the 58th Annual Meeting of the American Society of Artificial ORGANS in SAN FRANCISCO BAY AREA.The survey of 250 sufferers with schizophrenia, 250 caregivers, including family and close friends, and 400 psychiatrists got four objectives: Assess caregiver, patient and healthcare professional sights on treatment and awareness of available treatment plans for schizophrenia, Determine the issues that lead to an exacerbation of symptoms and how this impacts caregiver-patient-healthcare professional relationship Identify the amount of caregiver, affected individual and healthcare professional satisfaction with patient support systems Understand the impact of schizophrenia and episodic events in achieving affected person goals Additional information concerning this survey is available upon request and will be offered publicly by Janssen later on..